Patents
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
05/2004
05/21/2004WO2004041266A1 Receptor function controlling agent
05/21/2004WO2003084929A8 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa
05/21/2004CA2505322A1 Receptor function regulator
05/20/2004US20040097755 Ionic liquids and their use as solvents
05/20/2004US20040097754 Three-dimensional catalyst support structure carrying reducible metal oxide with a Group 8 promoter metal; preparing a carboxylic acid or nitrile by adding an additional catalyst and oxygen source or ammonia
05/20/2004US20040097602 Gelling agents or thickeners
05/20/2004US20040097593 Compounds for treatment of inflammation, diabetes and related disorders
05/20/2004US20040097589 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
05/20/2004US20040097585 4-(2,6-difluorophenyl)-4-oxobutyric acid and derivatives; milder side effects; insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis, arteriosclerosis
05/20/2004US20040097500 Compounds and compositions for delivering active agents
05/19/2004EP1420006A1 Alkylenebisnaphtol derivatives and charge control agent comprising the same
05/19/2004EP1419138A1 N- (1-dimethylaminocycloalkyl)methyl]benzamide derivatives
05/19/2004EP1095932B1 Phenoxyacetic acid derivatives and medicinal compositions containing the same
05/19/2004EP1047664B1 Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
05/19/2004DE60003103T2 Substituierte dimere Verbindungen Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen Substituted dimeric compounds process for their preparation and their pharmaceutical compositions
05/19/2004DE10250743A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
05/13/2004WO2004039865A1 Polyamine derivatives, a process to make them, and their use
05/13/2004WO2004039764A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds
05/13/2004WO2004039762A1 Phenethanolamine derivatives for the treatment of respiratory diseases
05/13/2004WO2004039753A2 Phenyl compounds
05/13/2004WO2004026305A9 Diaryl ethers as opioid receptor antagonist
05/13/2004US20040092598 Antiproliferative agnets; anticancer agents; skin disorders
05/13/2004US20040092594 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
05/13/2004US20040092518 Compounds for the treatment of metabolic disorders
05/13/2004US20040092516 Insulin resistance; antidiabetic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders
05/13/2004US20040092015 Coupling; binding aldehyde compound forming hydrazone compound; lipophilic vector
05/13/2004CA2503735A1 Polyamine derivatives, a process to make them, and their use
05/12/2004EP1163208B1 Caspase inhibitors and uses thereof
05/12/2004EP0915833B1 Fluorination of ketoamides
05/12/2004EP0912498B1 4(4-oxocyclohexyl) benzamides as intermediate products for medicaments
05/12/2004CN1495157A Preparation method of cyanophthaofluoroaniline
05/11/2004US6734203 Fused imidazolium derivatives
05/06/2004WO2004037751A2 Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof
05/06/2004WO2004037750A2 Short-acting sedative hypnotic agents for anesthesia and sedation
05/06/2004WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/06/2004US20040087794 Alpha bromination of p-(3-(dimethylaminocarbonyl)propionyl)-toluene
05/06/2004US20040087655 6-Substituted indanoyl amino acid conjugates as mimics to the biological activity of coronatine
05/06/2004US20040087650 Inhibitors of IMPDH enzyme
05/06/2004US20040087590 Novel biphenyl and biphenyl-like cannabinoids
05/06/2004US20040087582 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents
05/06/2004US20040087491 Electrophilic ketones for the treatment of herpesvirus infections
05/06/2004US20040087453 Photo-labile pro-fragrance conjugates
05/06/2004US20040086462 Radio-opaque polymer biomaterials
05/06/2004US20040086461 Radio-opaque polymer biomaterials
05/06/2004US20040086458 Radio-opaque polymer biomaterials
05/06/2004EP1414788A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
05/06/2004EP1414787A1 New derivatives of substituted anilines with herbicidal activity
05/06/2004EP1414786A1 Process for obtaining n-monosubstituted amides
05/06/2004EP1414784A2 Amphiphilic star-like macromolecules for drug delivery
05/06/2004EP1414780A1 Interfacial method of preparing ester-substituted diaryl carbonates
05/06/2004CA2497060A1 Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof
05/05/2004CN1494527A Or tho-substituted and meta-substituted bis-aryl compounds, method for production thereof, their use as medicament, and pharmaceutical preparations containing there compounds
05/05/2004CN1494425A Carboxamide derivatives as therapeutic agents
05/05/2004CN1494420A Compounds and compositions for delivering active agents
04/2004
04/29/2004WO2004035736A2 Halogenated selective androgen receptor modulators and methods of use thereof
04/29/2004WO2004035525A1 Inhibitors of histone deacetylase
04/29/2004WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
04/29/2004US20040082664 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition
04/29/2004US20040082625 Osteoporosis, bone disorders
04/29/2004CA2588083A1 Selective androgen receptor modulators and methods of use thereof
04/29/2004CA2502355A1 Halogenated selective androgen receptor modulators and methods of use thereof
04/29/2004CA2501265A1 Inhibitors of histone deacetylase
04/28/2004EP1412322A2 Protected 3.5-dihydroxy-2.2-dimethyl-valeroamides for the synthesis of epothilone and derivatives and method for the production and use thereof
04/28/2004EP1412320A1 Linked cyclitols and their polysulfated derivatives
04/28/2004EP1200384B1 2-alkyl-5-halogen-pent-4-ene carboxylic acids and their production
04/28/2004EP0585366B1 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
04/28/2004CN1492852A N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD
04/28/2004CN1492763A Compositions for delivering bisphosphonates
04/28/2004CN1147483C Adamantane derivatives
04/27/2004US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases
04/27/2004US6727237 Alkylating 5-nitroindole with 6-bromohexyl acetate to form a 6-(N-(5-nitroindolyl)) hexyl acetate, hydrolyzing to form alcohol of above ester, estrifying with nicotinic acid, and methylating the intermediate
04/22/2004WO2004033414A1 Mu opioid receptor ligands: methods of use and synthesis
04/22/2004WO2003041728A9 Novel phenyl-propargylether derivatives
04/22/2004US20040077896 Compounds for the treatment of metabolic disorders
04/22/2004US20040077728 Retiferol derivatives and their use in the treatment of skin diseases or conditions associated with photodamage
04/22/2004US20040077694 Malonamic acids and derivatives thereof as thyroid receptor ligands
04/22/2004US20040077628 Melanin-concentrating hormone antagonist
04/21/2004EP1409563A1 Photoactive materials
04/21/2004EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
04/21/2004EP1154987B1 Phenylalaninol derivatives
04/21/2004EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
04/21/2004CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical
04/21/2004CN1491207A Acylated indanyl amines and their use as pharmaceuticals
04/21/2004CN1146542C Benzamide derivatives and their use as cytokine inhibitors
04/21/2004CN1146536C Cycloethylene derivatives
04/20/2004US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
04/20/2004US6723743 Treating patient suffering from rheumatoid arthritis, psoriasis, bronchial asthma, alzheimer's disease, myocardial infarction or atherosclerosis
04/15/2004WO2004031129A2 Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
04/15/2004WO2004031128A1 Improved method for the production of n-substituted amides from nitriles
04/15/2004WO2004031118A1 Lpa receptor antagonists
04/15/2004WO2004031107A1 Method for the production of at least one partial propylene oxidation and/or ammoxidation product
04/15/2004WO2004031106A1 Method for the production of at least one partial propylene oxidation and/or ammoxidation product
04/15/2004WO2003083063A3 Common ligand mimics: naphtoates
04/15/2004US20040072880 Cycloalkyl inhibitors of potassium channel function
04/15/2004US20040072878 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage
04/15/2004US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders
04/15/2004US20040072307 Processes for enhanced production of pantothenate
04/15/2004US20040071187 Compound having at least two aromatic rings substituted with at least one carboxy group
04/15/2004CA2500935A1 Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
04/14/2004EP1406860A1 Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 157